Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP718116.RAK-TsfJPShbEZkrj6bcjyRgp9qz8lnn_ar2xXHDJh8VE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP718116.RAK-TsfJPShbEZkrj6bcjyRgp9qz8lnn_ar2xXHDJh8VE130_assertion type Assertion NP718116.RAK-TsfJPShbEZkrj6bcjyRgp9qz8lnn_ar2xXHDJh8VE130_head.
- NP718116.RAK-TsfJPShbEZkrj6bcjyRgp9qz8lnn_ar2xXHDJh8VE130_assertion description "[In contrast, expression levels of E2F-3 mRNA were lower in 70% (21/30) of the gastric carcinomas and in 20% (1/5) of the colorectal carcinomas than in their corresponding normal counterparts, while gross alteration of the E2F-3 gene was not detected.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718116.RAK-TsfJPShbEZkrj6bcjyRgp9qz8lnn_ar2xXHDJh8VE130_provenance.
- NP718116.RAK-TsfJPShbEZkrj6bcjyRgp9qz8lnn_ar2xXHDJh8VE130_assertion evidence source_evidence_literature NP718116.RAK-TsfJPShbEZkrj6bcjyRgp9qz8lnn_ar2xXHDJh8VE130_provenance.
- NP718116.RAK-TsfJPShbEZkrj6bcjyRgp9qz8lnn_ar2xXHDJh8VE130_assertion SIO_000772 10225440 NP718116.RAK-TsfJPShbEZkrj6bcjyRgp9qz8lnn_ar2xXHDJh8VE130_provenance.
- NP718116.RAK-TsfJPShbEZkrj6bcjyRgp9qz8lnn_ar2xXHDJh8VE130_assertion wasDerivedFrom befree-20140225 NP718116.RAK-TsfJPShbEZkrj6bcjyRgp9qz8lnn_ar2xXHDJh8VE130_provenance.
- NP718116.RAK-TsfJPShbEZkrj6bcjyRgp9qz8lnn_ar2xXHDJh8VE130_assertion wasGeneratedBy ECO_0000203 NP718116.RAK-TsfJPShbEZkrj6bcjyRgp9qz8lnn_ar2xXHDJh8VE130_provenance.